CTV Montreal shares the news that three major projects fighting breast cancer are getting an extra $10 million in funding from the Canadian Cancer Society and other partners. One of these projects is a collaboration between Aspect Biosystems, Merck, GlaxoSmithKline, and the Goodman Cancer Research Centre at McGill University. Through this collaboration, Dr. Morag Park at the Goodman Cancer Research Centre will use an RX1™ Bioprinter to reproduce a tumour from the cells of a breast cancer patient.
Read our press release here to learn more about this collaboration.
Watch the video from CTV News below to hear from Dr. Morag Park and learn about the impact of these projects.Back to all